Tech Company Financing Transactions
BIOWEG Funding Round
BIOWEG secured a $19 million Series A venture capital round on 9/16/2025. Investors included Axeleo Capital, BonVenture and European Innovation Council Fund.
Transaction Overview
Company Name
Announced On
9/16/2025
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support the commercialisation and construction of its bacterial cellulose plant in Germany and accelerate market entry across Europe.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Professor-von-Klitzing-Straße 11
Quakenbrück, 49610
Germany
Quakenbrück, 49610
Germany
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our Mission Is To Improve Billions Of Lives Through Sustainable Bioinnovation; Founded as Cellulosic Technologies (now BIOWEG) in 2019 in Germany, we are a purpose-driven organization powered by conscious ChemDesign. We match Bioinnovation to business problems. We explore and combine biotechnology, material science and molecular simulations learning to create and sell advanced sustainable and bio-based high-performance ingredients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Srinivas Karuturi
Founder
Prateek Mahalwar
Browse more venture capital transactions:
Prev: 9/16/2025: Figure AI venture capital transaction
Next: 9/16/2025: CreatorDB venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs